tirzepatide sleep apnea study in Obesity-Related Obstructive Apnea: Beyond Weight Loss Toward Disease Modification? Eli Lilly's tirzepatide gained FDA

It is still only FDA approved to treat Type 2 diabetes and to lower the risk of cardiovascular events in adults with Type 2 diabetes and known heart disease

Manufacturers therefore face the same incentives confronting companies outside health care: reduce prices or lose customers and profits

A condition called porphyria results from functional vitamin B2, with porphyria being one of the classic symptoms of autism

This triangulation between biopsy, NITs, and systemic cardiometabolic measures helps validate the biological plausibility of the treatment effect and supports the use of NITs in future biopsy-sparing strategies